Skip to main content

Table 1 Clinicopathologic characteristics of the four cohorts

From: Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Characteristic

HCC (n = 9)

CCa (n = 4)

GBC (n = 3)

PCa (n = 1)

p value

Age at surgery, years

58 [49–62]

67 [60–72]

49 [38–66]

64 [64]

0.438

Gender (male/female)

8 (89)/1 (11)

1 (25)/3 (75)

2 (67)/1 (33)

1 (100)/0 (0)

0.082

ASA score III/IV

9 (100)

3 (75)

3 (100)

1 (100)

0.559

Prior abdominal surgery

6 (67)

3 (75)

3 (100)

0 (0)

0.626

Synchronous/metachronous PC

1 (11)/8 (89)

2 (50)/2 (50)

0 (0)/3 (100)

1 (100)/0 (0)

0.082

Neoadjuvant chemotherapy

1 (11)

2 (50)

3 (100)

1 (100)

0.012*

  1. HCC hepatocellular carcinoma, CCa cholangiocarcinoma, GBC gallbladder cancer, PCa pancreatic cancer, PC peritoneal carcinomatosis
  2. * p<0.05